Home β€Ί Stock analysis β€Ί AKAN

Akanda (AKAN) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

AKAN dips 1.5% to $1.31, a 52-week low, 6 down days in a row. Closed at $1.31, -1.50% vs the prior close of $1.33. Day range $1.27–$1.36, opened at $1.36.

Last close$1.31-1.50%
Day range1.27–1.36
Open1.36
Volume99.10K
52-week range1.27–78.90
Avg volume (20d)867.98K

AKAN daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 β€” AKAN dips 1.5% to $1.31, a 52-week low, 6 down days in a row
Oct 14, 2026 β€” AKAN slides 3.6% to $1.33, a 52-week low, 5 down days in a row
Oct 13, 2026 β€” AKAN slides 15.9% to $1.38, a 52-week low, 4 down days in a row
Oct 12, 2026 β€” AKAN slides 6.8% to $1.64, a 52-week low, 3 down days in a row
Oct 9, 2026 β€” AKAN dips 1.1% to $1.76, a 52-week low
Oct 8, 2026 β€” AKAN slides 7.8% to $1.78, a 52-week low
Oct 7, 2026 β€” AKAN rises 2.1% to $1.93
Oct 6, 2026 β€” AKAN dips 1.0% to $1.89, a 52-week low, 8 down days in a row
Oct 5, 2026 β€” AKAN slides 3.5% to $1.91, a 52-week low, 7 down days in a row
Oct 2, 2026 β€” AKAN slides 10.4% to $1.98, a 52-week low, 6 down days in a row

AKAN latest news & SEC filings

Every SEC filing by or about AKAN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 1, 2026 Β· Form F-1 β€” F-1 filing

F-1 filing

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001213900-26-105921

Sep 30, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-105355

Sep 25, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-103621

Sep 9, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-098448

Sep 4, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-097448

Aug 17, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-090813

Aug 13, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-089076

Jun 18, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-070188

Things to know before you trade AKAN

AKAN market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 20261.361.361.271.3199.10K
Oct 14, 20261.421.421.321.33100.70K
Oct 13, 20261.601.601.381.38129.70K
Oct 12, 20261.751.761.641.64107.40K
Oct 9, 20261.791.831.751.7664.00K
Oct 8, 20261.941.941.731.7896.10K
Oct 7, 20261.901.991.871.9386.00K
Oct 6, 20261.951.961.861.8957.60K
Oct 5, 20261.941.961.851.9185.30K
Oct 2, 20262.092.091.941.98221.90K
Oct 1, 20262.572.572.202.21288.10K
Sep 30, 20262.532.582.462.5780.90K
Sep 29, 20262.822.822.542.57125.40K
Sep 28, 20262.952.962.802.83136.50K
Sep 25, 20263.093.153.053.0598.10K
Sep 24, 20263.023.202.953.13232.80K
Sep 23, 20263.153.242.973.11339.30K
Sep 22, 20263.233.453.123.235.20M
Sep 21, 20262.983.132.963.06296.30K
Sep 18, 20263.223.582.823.229.52M

About Akanda

Akanda (AKAN) is listed on the Nasdaq and classified by the SEC under β€œMedicinal Chemicals & Botanical Products”. Its business address is in NEW ROMNEY, United Kingdom. State of incorporation: Ontario, Canada. Fiscal year ends December 31. SEC CIK 1888014.

AKAN board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
Jan 16, 2026Financial Lp HrtSale7,868$1.29
Jan 15, 2026Financial Lp HrtBuy29,036$1.40

AKAN financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

AKAN earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Medicinal Chemicals & Botanical Products

Definium Therapeutics (DFTX)Regencell Bioscience (RGC)Trulieve Cannabis (TRLV)Tilray Brands (TLRY)Aurora Cannabis (ACB)Glass House Brands (GLAS)Usana Health Sciences (USNA)Cronos (CRON)Canopy Growth (CGC)Sndl (SNDL)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on AKAN

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.